NEW YORK (GenomeWeb) – NanoString Technologies today priced its public offering of 4 million shares of common stock at $12.50 per share.

The firm had announced its intention to offer $50 million worth of stock earlier this week.

NanoString also granted underwriters of the offering a 30-day option to purchase up to an additional 600,000 shares of common stock at the public offering price.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.